Deutsche Bank AG Has $78.61 Million Stock Position in STERIS plc (NYSE:STE)

Deutsche Bank AG grew its stake in STERIS plc (NYSE:STE) by 19.7% during the 4th quarter, HoldingsChannel reports. The firm owned 382,407 shares of the medical equipment provider’s stock after acquiring an additional 62,968 shares during the quarter. Deutsche Bank AG’s holdings in STERIS were worth $78,608,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. EP Wealth Advisors LLC boosted its stake in STERIS by 20.1% in the 4th quarter. EP Wealth Advisors LLC now owns 1,011 shares of the medical equipment provider’s stock valued at $208,000 after buying an additional 169 shares in the last quarter. Colonial Trust Co SC raised its stake in STERIS by 5.5% during the fourth quarter. Colonial Trust Co SC now owns 11,955 shares of the medical equipment provider’s stock worth $2,457,000 after acquiring an additional 622 shares in the last quarter. Centiva Capital LP bought a new position in shares of STERIS during the fourth quarter valued at $636,000. Captrust Financial Advisors lifted its holdings in shares of STERIS by 65.7% during the fourth quarter. Captrust Financial Advisors now owns 16,743 shares of the medical equipment provider’s stock valued at $3,442,000 after acquiring an additional 6,638 shares during the period. Finally, Cary Street Partners Financial LLC acquired a new stake in shares of STERIS in the 4th quarter valued at $80,000. 94.69% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have commented on STE. JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a research note on Thursday, April 10th. Stephens raised STERIS to a “strong-buy” rating in a report on Thursday, May 1st. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research note on Monday, April 7th. Finally, Piper Sandler increased their target price on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $258.75.

STERIS Price Performance

Shares of STE stock opened at $226.54 on Monday. STERIS plc has a 1 year low of $200.98 and a 1 year high of $248.24. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The firm’s 50 day moving average is $223.40 and its 200-day moving average is $218.80. The firm has a market capitalization of $22.26 billion, a price-to-earnings ratio of 48.10 and a beta of 0.96.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Shareholders of record on Tuesday, June 10th will be issued a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a yield of 1.01%. The ex-dividend date is Tuesday, June 10th. STERIS’s dividend payout ratio is 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.